Equities

BML Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

BML Inc

Actions
  • Price (USD)24.10
  • Today's Change0.00 / 0.00%
  • Shares traded8.85k
  • 1 Year change--
  • Beta0.4670
Data delayed at least 15 minutes, as of Jan 08 2026 16:15 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

BML Inc is a Japan-based company primarily engaged in the testing business. Data processed in the host core system is reported to customers as test results. Customer unit price data and specimen testing performance data held by the host core system become billing data for customers, which is then linked to the automatic recording of sales. Other businesses include the medical information systems business. The testing business segment undertakes contract work such as clinical testing, while the medical information systems business segment manufactures and sells system equipment for medical institutions and provides medical information services.

  • Revenue in JPY (TTM)149.09bn
  • Net income in JPY7.56bn
  • Incorporated1955
  • Employees4.56k
  • Location
    BML Inc5-21-3, SendagayaSHIBUYA-KU 151-0051JapanJPN
  • Phone+81 333500111
  • Fax+81 333501180
  • Websitehttp://www.bml.co.jp/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.